{
    "eid": "2-s2.0-85042551227",
    "title": "Survival Benefits from Metformin Use in Pancreatic Cancer: A Systemic Review and Meta-analysis",
    "cover-date": "2018-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Internal Medicine",
            "@code": "2724",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Endocrinology, Diabetes and Metabolism",
            "@code": "2712",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Endocrinology",
            "@code": "1310",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [],
    "authors": [
        "Kamonkiat Wirunsawanya",
        "Veeravich Jaruvongvanich",
        "Sikarin Upala"
    ],
    "citedby-count": 5,
    "ref-count": 10,
    "ref-list": [
        "Effect of metformin use on survival in resectable pancreatic cancer: A single-institution experience and review of the literature",
        "Metformin use is associated with improved survival in patients undergoing resection for pancreatic cancer",
        "Metformin use and survival of patients with pancreatic cancer: A cautionary lesson",
        "Metformin and survival in pancreatic cancer: A retrospective cohort study",
        "Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: A nationwide population-based study in Korea",
        "Metformin in patients with advanced pancreatic cancer: A double-blind, randomised, placebo-controlled phase 2 trial",
        "Statin and metformin use prolongs survival in patients with resectable pancreatic cancer",
        "Metformin use is associated with better survival of diabetic patients with pancreatic cancer",
        "Metabolic roles of AMPK and metformin in cancer cells",
        "The complexities of obesity and diabetes with the development and progression of pancreatic cancer"
    ],
    "affiliation": [
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60023366",
            "affilname": "Rangsit University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Honolulu",
            "@id": "60013791",
            "affilname": "University of Hawai\u02bbi at M\u0101noa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013791",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60011189",
            "affilname": "Faculty of Medicine Siriraj Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011189",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}